title: Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.
authors.affiliation: Centre régional de Pharmacovigilance, Hôpital Fernand-Widal, AP-HP, Paris, France. pharmacovigilance.fwd.lrb@aphp.fr.
authors.forename: Patrick
authors.initials: P
authors.lastname: Carlier
authors.affiliation: Centre régional de Pharmacovigilance, Hôpital Fernand-Widal, AP-HP, Paris, France.
authors.forename: Maritza
authors.initials: M
authors.lastname: Markarian
authors.affiliation: Centre régional de Pharmacovigilance, Hospices Civils de Lyon, Lyon, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Bernard
authors.affiliation: Centre régional de Pharmacovigilance, CHRU Angers, Angers, France.
authors.forename: Laurence
authors.initials: L
authors.lastname: Lagarce
authors.affiliation: Centre régional de Pharmacovigilance, CHU Dijon, Dijon, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Dautriche
authors.affiliation: Centre régional de Pharmacovigilance du Nord Pas de Calais, CHU Lille, 59000, Lille, France.
authors.forename: Johanna
authors.initials: J
authors.lastname: Béné
authors.affiliation: Centre régional de Pharmacovigilance, CHU Grenoble Alpes, Grenoble, France.
authors.forename: Nathalie Fouilhe
authors.initials: NF
authors.lastname: Sam-Lai
authors.affiliation: Centre régional de Pharmacovigilance, Hôpital Fernand-Widal, AP-HP, Paris, France.
authors.forename: Pirayeh
authors.initials: P
authors.lastname: Eftekhari